Evaluating the Performance of Classical PK Models, 2nd‐Gen MPBPK Models, and MPBPK Models with TMDD in Predicting Therapeutic Monoclonal Antibody PK in Human

TY - JOUR

T1 - Evaluating the Performance of Classical PK Models, 2nd‐Gen MPBPK Models, and MPBPK Models with TMDD in Predicting Therapeutic Monoclonal Antibody PK in Human

AU - Liu, Xiaoxi

AU - Wang, Y.

AU - Sherwin, Catherine M.T.

PY - 2018/3/1

Y1 - 2018/3/1

UR - https://corescholar.libraries.wright.edu/pediatrics/313

UR - https://doi.org/10.1002/cpt.993

U2 - 10.1002/cpt.993

DO - 10.1002/cpt.993

M3 - Article

VL - 103

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

ER -